Evaluation of platelet lysate as a substitute for FBS in explant and enzymatic isolation methods of human umbilical cord MSCs
Abstract Mesenchymal stem cells (MSCs) have immense potential for cell-based therapy of acute and chronic pathological conditions. MSC transplantation for cell-based therapy requires a substantial number of cells in the range of 0.5–2.5 × 106 cells/kg body weight of an individual. A prolific source...
Guardado en:
Autores principales: | Sangeetha Kandoi, Praveen kumar L, Bamadeb Patra, Prasanna Vidyasekar, Divya Sivanesan, Vijayalakshmi S., Rajagopal K., Rama Shanker Verma |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/34faa0aa839048879168ebc459453cc1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PTEN/FOXO3/AKT pathway regulates cell death and mediates morphogenetic differentiation of Colorectal Cancer Cells under Simulated Microgravity
por: Raj Pranap Arun, et al.
Publicado: (2017) -
Human Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia
por: Guilian Liao, et al.
Publicado: (2021) -
An engineered high affinity Fbs1 carbohydrate binding protein for selective capture of N-glycans and N-glycopeptides
por: Minyong Chen, et al.
Publicado: (2017) -
Immunomodulation and Regenerative Capacity of MSCs for Long-COVID
por: Xin Ya Loke, et al.
Publicado: (2021) -
Topical Platelet Lysate Hydrogel in Patients With Anal Fissure
por: Akram Jamshidzadeh, et al.
Publicado: (2014)